Exercise capacity impairment in COPD patients with comorbidities

被引:6
作者
Da Silva, G. P. F. [1 ,3 ]
Pessoa Morano, M. T. A. [2 ]
De Matos Cavalcante, A. G. [1 ]
De Andrade, N. M. [1 ]
De Francesco Daher, E. [1 ]
Pereira, E. D. B. [1 ]
机构
[1] Univ Fed Ceara UFC, Fortaleza, Ceara, Brazil
[2] Hosp Messejana Dr Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil
[3] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil
关键词
Exercise capacity; Health status; COPD; Comorbidity; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ARTERIAL STIFFNESS; EMPHYSEMA; MORTALITY; ANXIETY; IMPACT; INTERVENTION;
D O I
10.1016/j.rppnen.2015.04.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Comorbidities are common in COPD and have been associated with reduced health status, increased health care utilization, all-cause hospitalization, and mortality. There is a scarcity of data on the relationship between comorbidities and functional capacity. Objective: to evaluate the impact of comorbidities on functional capacity of COPD patients. Methods: a cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil. The functional capacity was assessed by spirometry and the 6-min walking test (6MWT). The health status was assessed by the St. George's respiratory questionnaire (SGRQ) and the COPD assessment test (CAT). The sample was stratified as having "none", "one" and "two or three'' comorbidities groups. One-way ANOVA was used to compare means of the three groups and a multiple linear regression was run to predict the impact of comorbidities on 6MWT. Results: Comorbidities (hypertension, coronary disease and diabetes) were found in 54% of the studied patients. The mean age of the 79 patients was 67 +/- 8 years and 55% were male. CAT scores increased from "no comorbidity" (17.9 +/- 7.7) to "one comorbidity" (22.8 +/- 6.8) and "two or three comorbidities" groups (24.2 +/- 10.2). A post hoc test showed a significant difference in the "no comorbidity" compared to the "two or three comorbidities" groups (p = 0.01). The distance walked by the patients decreased from "no comorbidity" (386.1 +/- 83.2 m) to "one comorbidity" (350 +/- 98 m) and "two or three comorbidities" groups (312.6 +/- 91 m). A post hoc test showed significant difference in the "no comorbidity" compared to "two or three comorbidities" groups (p = 0.007). Numbers of comorbidities were independently associated with the 6 MWT adjusting for age, severity of COPD and CAT scores. Conclusion: in the studied sample, the presence of comorbidities contributed to impair exercise capacity in patients with COPD. (C) 2014 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [41] Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD
    Vonbank, Karin
    Funk, Georg Christian
    Marzluf, Beatrice
    Burian, Bernhard
    Ziesche, Rolf
    Stiebellehner, Leopold
    Petkov, Ventzislav
    Haber, Paul
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (23-24) : 749 - 755
  • [42] Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD
    Al-shair, Khaled
    Dockry, Rachel
    Mallia-Milanes, Brendan
    Kolsum, Umme
    Singh, Dave
    Vestbo, Jorgen
    [J]. RESPIRATORY MEDICINE, 2009, 103 (10) : 1572 - 1579
  • [43] An Integrated Index Combined by Dynamic Hyperinflation and Exercise Capacity in the Prediction of Morbidity and Mortality in COPD
    Ozguer, Eylem Sercan
    Nayci, Sibel Atis
    Ozge, Cengiz
    Tasdelen, Bahar
    [J]. RESPIRATORY CARE, 2012, 57 (09) : 1452 - 1459
  • [44] COPD and its comorbidities: Impact, measurement and mechanisms
    Negewo, Netsanet A.
    Gibson, Peter G.
    McDonald, Vanessa M.
    [J]. RESPIROLOGY, 2015, 20 (08) : 1160 - 1171
  • [45] Comorbidities in COPD: A new challenge in clinical practice
    Couillard, A.
    Veale, D.
    Muir, J. -F.
    [J]. REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 (03) : 143 - 153
  • [46] Comorbidities in COPD: Current and Future Treatment Challenges
    Mariniello, Domenica Francesca
    D'Agnano, Vito
    Cennamo, Donatella
    Conte, Stefano
    Quarcio, Gianluca
    Notizia, Luca
    Pagliaro, Raffaella
    Schiattarella, Angela
    Salvi, Rosario
    Bianco, Andrea
    Perrotta, Fabio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [47] How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD?
    Boer, Lonneke M.
    Asijee, Guus M.
    van Schayck, Onno C. P.
    Schermer, Tjard R. J.
    [J]. PRIMARY CARE RESPIRATORY JOURNAL, 2012, 21 (02): : 202 - 207
  • [48] Prevalence of comorbidities in COPD patients by disease severity in a German population
    Greulich, Timm
    Weist, Benjamin J. D.
    Koczulla, Andreas Rembert
    Janciauskiene, Sabina
    Klemmer, Andreas
    Lux, Wolfram
    Alter, Peter
    Vogelmeier, Claus F.
    [J]. RESPIRATORY MEDICINE, 2017, 132 : 132 - 138
  • [49] Pain in Veterans with COPD: relationship with physical activity and exercise capacity
    Raphaely, Rebecca A.
    Mongiardo, Maria A.
    Goldstein, Rebekah L.
    Robinson, Stephanie A.
    Wan, Emily S.
    Moy, Marilyn L.
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [50] Exercise capacity in COPD patients with exercise- induced pulmonary hypertension
    Skjorten, Ingunn
    Hilde, Janne Mykland
    Melsom, Morten Nissen
    Hisdal, Jonny
    Hansteen, Viggo
    Steine, Kjetil
    Humerfelt, Sjur
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3599 - 3610